Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

134
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
134
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

157
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
157
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

104
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
104
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

95
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
95
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

112
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
112
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

109
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
109

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extraction of Protruding Ostial Stents to Enable Percutaneous Coronary Interventions: The EXPOSE Technique.

JACC. Case reports·2026
Same author

Recovery of a Broken Snare in Coronary Intervention.

JACC. Case reports·2026
Same author

<i>Staphylococcus lugdunensis</i>-Infected Left Atrial Myxoma Complicated by Mitral Valve Endocarditis and Septic Emboli: A Case Report.

Clinical case reports·2026
Same author

A perspective on the future of heart failure research.

Journal of molecular and cellular cardiology plus·2026
Same author

Deep learning for estimating right ventricular function from routine coronary angiography.

European heart journal. Digital health·2026
Same author

Outcomes of Left Atrial Appendage Occlusion in Patients With Hypertrophic Cardiomyopathy, Rheumatic Heart Disease, and Cardiac Amyloidosis.

JACC. Clinical electrophysiology·2026
Same journal

Beyond vasodilation: sotatercept and the remodeling hypothesis in hfpef-associated pulmonary hypertension.

Heart failure reviews·2026
Same journal

Beyond the right ventricle: left heart involvement in pulmonary arterial hypertension.

Heart failure reviews·2026
Same journal

Left ventricular non-compaction in heart failure: contemporary perspective on diagnostic challenges and treatment opportunities.

Heart failure reviews·2026
Same journal

Correction to: Left atrial shunting devices: why, what, how, and… when?

Heart failure reviews·2026
Same journal

Cardiac microcurrent therapy in heart failure: Mechanistic rationale, early clinical evidence, and future directions.

Heart failure reviews·2026
Same journal

Cardiac imaging in Chagas cardiomyopathy for phenotypic characterisation and risk stratification.

Heart failure reviews·2026
See all related articles

Related Experiment Video

Updated: Oct 29, 2025

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.5K

Ventricular non-compaction review.

Shaurya Srivastava1, Majid Yavari2, Abdullah Al-Abcha2

  • 1Department of Internal Medicine, Michigan State University, East Lansing, USA. srivas28@msu.edu.

Heart Failure Reviews
|July 7, 2021
PubMed
Summary
This summary is machine-generated.

Left ventricular non-compaction cardiomyopathy (LVNC) is a rare heart condition. This review covers its causes, diagnosis, and management, highlighting the need for standardized guidelines.

Keywords:
CardiomyopathyCongenitalHeart failureNon-compaction

More Related Videos

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

7.1K
Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

3.0K

Related Experiment Videos

Last Updated: Oct 29, 2025

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.5K
Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

7.1K
Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

3.0K

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Genetics

Background:

  • Left ventricular non-compaction cardiomyopathy (LVNC) is a rare, unclassified cardiomyopathy.
  • It can lead to heart failure, arrhythmias, and embolic events in adults.
  • Diagnostic criteria across echocardiography, CMR, and CT imaging are not standardized.

Purpose of the Study:

  • To provide a comprehensive review of LVNC.
  • To discuss etiologies, pathogenesis, and diagnostic criteria.
  • To explore current management and treatment strategies, addressing data limitations.

Main Methods:

  • Literature review of existing studies on LVNC.
  • Analysis of diagnostic imaging modalities (echocardiography, CMR, CT).
  • Review of current management practices and treatment debates.

Main Results:

  • LVNC diagnosis lacks standardized criteria, complicating management.
  • The condition presents in various forms, influencing treatment approaches.
  • Evidence for definitive management guidelines regarding anticoagulation and arrhythmia prevention is limited.

Conclusions:

  • LVNC requires further research to establish diagnostic standards.
  • Standardized management guidelines are needed to improve patient outcomes.
  • Comprehensive understanding of LVNC's diverse presentations is crucial for effective treatment.